Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Income from Non-Controlling Interests: 2009-2024

Historic Income from Non-Controlling Interests for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $36,055.

  • Cumberland Pharmaceuticals' Income from Non-Controlling Interests fell 216.45% to -$8,282 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9,456, marking a year-over-year decrease of 135.96%. This contributed to the annual value of $36,055 for FY2024, which is 170.08% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Income from Non-Controlling Interests stood at $36,055 for FY2024, which was up 170.08% from -$51,446 recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Income from Non-Controlling Interests registered a high of $36,055 during FY2024, and its lowest value of -$95,212 during FY2021.
  • Its 3-year average for Income from Non-Controlling Interests is -$31,730, with a median of -$51,446 in 2023.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first plummeted by 808.32% in 2020, then spiked by 170.08% in 2024.
  • Cumberland Pharmaceuticals' Income from Non-Controlling Interests (Yearly) stood at -$79,496 in 2020, then fell by 19.77% to -$95,212 in 2021, then grew by 16.19% to -$79,798 in 2022, then surged by 35.53% to -$51,446 in 2023, then soared by 170.08% to $36,055 in 2024.